Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pirepemat (IRL752) is a cortical-preferring catecholamine agent that enhances cognition. It is utilized in the investigation of Parkinson's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 789.00 | |
50 mg | Inquiry | $ 1,190.00 |
Description | Pirepemat (IRL752) is a cortical-preferring catecholamine agent that enhances cognition. It is utilized in the investigation of Parkinson's disease. |
In vitro | IRL752 displayed its highest in vitro affinities for 5-HT and NA-related targets[2]. |
In vivo | IRL752 (3.7-100 μmol/kg, s.c.), administered 30 minutes before testing in normal rats, did not significantly alter acute hyperdopaminergic or hypoglutamatergic motor responses. However, it effectively reversed motor deficits attributed to diminished monoaminergic function[2]. This compound induced dose-dependent and region-specific changes in indices of brain monoamine transmission and gene expression, without additional explanation, maintaining the original terminology and format requested. |
Synonyms | IRL752 |
Molecular Weight | 213.228 |
Formula | C11H13F2NO |
CAS No. | 1227638-29-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pirepemat 1227638-29-0 IRL-752 IRL 752 IRL752 inhibitor inhibit